EFDID: 537217EFD: View Filing

Issuer: Ensho Therapeutics, Inc. (0002032849) - D

Accession: 0002032849-24-000002 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0002032849
  • Entity Name:
    Ensho Therapeutics, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2024)
  • Address:
    422 MOUNTAIN WAY
    MORRIS PLAINS, NY 07950
  • Persons:
    Related Persons 6
    Neena Bitritto-Garg
    Executive Officer, Director, Promoter
    Bittoo Kanwar
    Executive Officer
    James Andrew Whitney
    Executive Officer
    Emily Weng
    Executive Officer
    Matthew McKevitt
    Executive Officer
    Danielle Fry
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    11/12/2024
  • First Sale Date:
    10/24/2024
  • Offering Amount:
    $12,500,000
  • Amount Sold:
    $5,000,000
  • Amount Remaining:
    $7,500,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:NY
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Ensho Therapeutics, Inc.Neena Bitritto-GargNeena Bitritto-GargPresident and CEO2024-11-12